Iron deficiency is associated with adverse outcome in Eisenmenger patients

European Heart Journal

Volumn 32, Issue 22, 2011, Pages 2790-2799

  Van De Bruaene, Alexander ^a   Delcroix, Marion ^a   Pasquet, Agnes ^b   De Backer, Julie ^c   De Pauw, Michel ^c   Naeije, Robert ^d   Vachiry, Jean Luc ^d   Paelinck, Bernard ^e   Morissens, Marielle ^f   Budts, Werner ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d ERASME HOSPITAL   (Belgium)

^e ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^f BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Eisenmenger syndrome; Iron deficiency; Oral anticoagulation; Outcome

Indexed keywords

ANTICOAGULANT AGENT; HEMOGLOBIN; IRON;

ADULT; ANTICOAGULATION; ARTICLE; CARDIOPULMONARY ARREST; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE REGISTRY; EISENMENGER COMPLEX; FEMALE; FOLLOW UP; HEMATOCRIT; HOSPITALIZATION; HUMAN; IRON DEFICIENCY; IRON DEPLETION; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MORTALITY; OUTCOME ASSESSMENT; OXYGEN SATURATION; PHLEBOTOMY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRANSPLANTATION;

ADULT; BELGIUM; EISENMENGER COMPLEX; FEMALE; HEMATOCRIT; HEMOGLOBINS; HOSPITALIZATION; HUMANS; IRON; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; OXYGEN; PROGNOSIS; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; TRANSFERRIN; YOUNG ADULT;

EID: 81855190691     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr130     Document Type: Article

References (33)

1. Rosenthal A, Mentzer WC, Eisenstein EB, Nathan DG, Nelson NM, Nadas AS. The role of red blood cell organic phosphates in adaptation to congenital heart disease. Pediatrics 1971;47:537-47.
2. Rosenthal A, Nathan DG, Marty AT, Button LN, Miettinen OS, Nadas AS. Acute hemodynamic effects of red cell volume reduction in polycythemia of cyanotic congenital heart disease. Circulation 1970;42:297-308.
3. Rosove MH, Perloff JK, Hocking WG, Child JS, Canobbio MM, Skorton DJ. Chronic hypoxaemia and decompensated erythrocytosis in cyanotic congenital heart disease. Lancet 1986;2:313-15. (Pubitemid 16069615)
4. Tay EL, Peset A, Papaphylactou M, Inuzuka R, Alonso-Gonzalez R, Giannakoulas G, Tzifa A, Goletto S, Broberg C, Dimopoulos K, Gatzoulis MA. Replacement therapy for iron deficiency improves exercise capacity and quality of life in patients with cyanotic congenital heart disease and/or the Eisenmenger syndrome. Int J Cardiol 2010 doi:10.1016/j.ijcard.2010.05.066.
5. Ammash N, Warnes CA. Cerebrovascular events in adult patients with cyanotic congenital heart disease. J Am Coll Cardiol 1996;28:768-72. (Pubitemid 26288663)
6. Broberg CS, Bax BE, Okonko DO, Rampling MW, Bayne S, Harries C, Davidson SJ, Uebing A, Khan AA, Thein S, Gibbs JS, Burman J, Gatzoulis MA. Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease. J Am Coll Cardiol 2006; 48:356-65.
7. Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, Banasiak W, Polonski L, Filippatos G, McMurray JJ, Anker SD, Ponikowski P. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 31:1872-80.
8. Cairo G, Bernuzzi F, Recalcati S. A precious metal: Iron, an essential nutrient for all cells. Genes Nutr 2006;1:25-39.
9. Beard JL. Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr 2001;131:568S-79S; discussion 580S.
10. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999;341:1986-95. (Pubitemid 30010408)
11. Oechslin E. Hematological management of the cyanotic adult with congenital heart disease. Int J Cardiol 2004;97(Suppl. 1):109-15. (Pubitemid 39601759)
12. Territo MC, Rosove MH. Cyanotic congenital heart disease: hematological management. J Am Coll Cardiol 1991;18:320-22.
13. Van de Bruaene A, Delcroix M, Pasquet A, De Backer J, De Pauw M, Naeije R, Vachiery JL, Paelinck B, Morissens M, BudtsW. The Belgian Eisenmenger syndrome registry: Implications for treatment strategieSa Acta Cardiol 2009;64:447-53.
14. Brugnara C. A hematologic "gold standard" for iron-deficient stateSa Clin Chem 2002;48:981-2. (Pubitemid 34680890)
15. Brugnara C. Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem 2003;49:1573-78. (Pubitemid 37194211)
16. Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem 1998;44:45-51. (Pubitemid 28042465)
17. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997;89:1052-57. (Pubitemid 27121300)
18. Heusser F, Fahey JT, Lister G. Effect of hemoglobin concentration on critical cardiac output and oxygen transport. Am J Physiol 1989;256:H527-32.
19. Hopkins WE, Waggoner AD. Severe pulmonary hypertension without right ventricular failure: the unique hearts of patients with Eisenmenger syndrome. Am J Cardiol 2002;89:34-8. (Pubitemid 34066583)
20. Daliento L, Somerville J, Presbitero P, Menti L, Brach-Prever S, Rizzoli G, Stone S. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J 1998;19:1845-55. (Pubitemid 28556655)
21. Diller GP, Gatzoulis MA. Pulmonary vascular disease in adults with congenital heart disease. Circulation 2007;115:1039-50. (Pubitemid 46328298)
22. Dimopoulos K, Inuzuka R, Goletto S, Giannakoulas G, Swan L, Wort SJ, Gatzoulis MA. Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension. Circulation 2010;121:20-5.
23. Galie N, Beghetti M, Gatzoulis MA, Granton J, Berger RM, Lauer A, Chiossi E, Landzberg M. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation 2006;114: 48-54. (Pubitemid 44305274)
24. Mukhopadhyay S, Sharma M, Ramakrishnan S, Yusuf J, Gupta MD, Bhamri N, Trehan V, Tyagi S. Phosphodiesterase-5 inhibitor in Eisenmenger syndrome: a preliminary observational study. Circulation 2006;114:1807-10. (Pubitemid 44673355)
25. Benza RL, Miller DP, Gomberg-Maitland M, Frantz RP, Foreman AJ, Coffey CS, Frost A, Barst RJ, Badesch DB, Elliott CG, Liou TG, McGoon MD. Predicting survival in pulmonary arterial hypertension: Insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation 2010;122:164-72.
26. Diller GP, Dimopoulos K, Broberg CS, Kaya MG, Naghotra US, Uebing A, Harries C, Goktekin O, Gibbs JS, Gatzoulis MA. Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: A combined retrospective and case-control study. Eur Heart J 2006;27:1737-42. (Pubitemid 44025362)
27. Linderkamp O, Klose HJ, Betke K, Brodherr-Heberlein S, Buhlmeyer K, Kelson S, Sengespeik C. Increased blood viscosity in patients with cyanotic congenital heart disease and iron deficiency. J Pediatr 1979;95:567-9. (Pubitemid 9247441)
28. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Luscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009;361:2436-48.
29. Koury MJ, Ponka P. New insights into erythropoiesis: The roles of folate, vitamin B12, and iron. Annu Rev Nutr 2004;24:105-31. (Pubitemid 38938788)
30. Spence MS, Balaratnam MS, Gatzoulis MA. Clinical update: Cyanotic adult congenital heart disease. Lancet 2007;370:1530-32. (Pubitemid 350027743)
31. Sandoval J, Aguirre JS, Pulido T, Martinez-Guerra ML, Santos E, Alvarado P, Rosas M, Bautista E. Nocturnal oxygen therapy in patients with the Eisenmenger syndrome. Am J Respir Crit Care Med 2001;164:1682-87. (Pubitemid 33124159)
32. Walker F, Mullen MJ, Woods SJ, Webb GD. Acute effects of 40% oxygen supplementation in adults with cyanotic congenital heart disease. Heart 2004;90: 1073-74. (Pubitemid 39127938)
33. Kaemmerer H, Fratz S, Braun SL, Koelling K, Eicken A, Brodherr-Heberlein S, Pietrzik K, Hess J. Erythrocyte indexes, iron metabolism, and hyperhomocysteinemia in adults with cyanotic congenital heart disease. Am J Cardiol 2004;94:825-28. (Pubitemid 39221514)